Sequence variants at CYP1A1-CYP1A2 and AHR associate with coffee consumption

Human Molecular Genetics

Volumn 20, Issue 10, 2011, Pages 2071-2077

  Sulem, Patrick ^a   Gudbjartsson, Daniel F ^a   Geller, Frank ^b   Prokopenko, Inga ^c,d   Feenstra, Bjarke ^b   Aben, Katja K H ^e,f   Franke, Barbara ^g   den Heijer, Martin ^f,g   Kovacs, Peter ^h   Stumvoll, Michael ⁱ   Mägi, Reedik ^c,d   Yanek, Lisa R ^j   Becker, Lewis C ^j   Boyd, Heather A ^b   Stacey, Simon N ^a   Walters, G Bragi ^a   Jonasdottir, Adalbjorg ^a   Thorleifsson, Gudmar ^a   Holm, Hilma ^a   Gudjonsson, Sigurjon A ^a   Rafnar, Thorunn ^a   Björnsdottir, Gyda ^a   Becker, Diane M ⁱ   Melbye, Mads ^b   Kong, Augustine ^a   Tönjes, Anke ⁱ   Thorgeirsson, Thorgeir ^a   Thorsteinsdottir, Unnur ^a,k   Kiemeney, Lambertus A ^e,f,g   Stefansson, Kari ^a,k   more..

^a DECODE GENETICS   (Iceland)

^b STATENS SERUM INSTITUT   (Denmark)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e Integraal Kankercentrum Oost   (Netherlands)

^f Biostatistics and HTA ^*  (Netherlands)

^g RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^h UNIVERSITY HOSPITAL LEIPZIG   (Germany)

ⁱ UNIVERSITY OF LEIPZIG   (Germany)

^j DEPARTMENT OF PATHOLOGY   (United States)

^k UNIVERSITY OF ICELAND   (Iceland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; CAFFEINE METABOLIZING ENZYME; CYTOCHROME P450 1A1; CYTOCHROME P450 1A2; DRUG METABOLIZING ENZYME; UNCLASSIFIED DRUG; XENOBIOTIC AGENT;

ARTICLE; CANCER REGISTRY; COFFEE; CORONARY ARTERY DISEASE; DRUG METABOLISM; FLUID INTAKE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE LOCATION; GENE LOCUS; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; GENOTYPE; GERMANY; HUMAN; ICELAND; MAJOR CLINICAL STUDY; META ANALYSIS; NETHERLANDS; PREGNANT WOMAN; PRIORITY JOURNAL; QUESTIONNAIRE; SINGLE NUCLEOTIDE POLYMORPHISM; UNITED STATES;

ADULT; AGED; ALLELES; CHROMOSOMES, HUMAN, PAIR 15; COFFEE; CYTOCHROME P-450 CYP1A1; CYTOCHROME P-450 CYP1A2; DRINKING BEHAVIOR; FEMALE; GENETIC VARIATION; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RECEPTORS, ARYL HYDROCARBON; SEX FACTORS;

EID: 79955393453     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddr086     Document Type: Article

References (29)

1. van Dam, R.M. (2008) Coffee consumption and risk of type 2 diabetes, cardiovascular diseases, and cancer. Appl. Physiol. Nutr. Metab., 33, 1269-1283.
2. Snyder, S.H., Katims, J.J., Annau, Z., Bruns, R.F. and Daly, J.W. (1981) Adenosine receptors and behavioral actions of methylxanthines. Proc. Natl Acad. Sci. USA, 78, 3260-3264.
3. Cnattingius, S., Signorello, L.B., Anneren, G., Clausson, B., Ekbom, A., Ljunger, E., Blot, W.J., McLaughlin, J.K., Petersson, G., Rane, A. et al. (2000) Caffeine intake and the risk of first-trimester spontaneous abortion. N. Engl. J. Med., 343, 1839-1845.
4. Riksen, N.P., Rongen, G.A. and Smits, P. (2009) Acute and long-term cardiovascular effects of coffee: implications for coronary heart disease. Pharmacol. Ther., 121, 185-191.
5. Rosso, A., Mossey, J. and Lippa, C.F. (2008) Caffeine: neuroprotective functions in cognition and Alzheimer's disease. Am. J. Alzheimers Dis. Other Demen., 23, 417-422.
6. Kawachi, I., Willett, W.C., Colditz, G.A., Stampfer, M.J. and Speizer, F.E. (1996) A prospective study of coffee drinking and suicide in women. Arch. Intern. Med., 156, 521-525.
7. Carmelli, D., Swan, G.E., Robinette, D. and Fabsitz, R.R. (1990) Heritability of substance use in the NAS-NRC Twin Registry. Acta Genet. Med. Gemellol. (Roma), 39, 91-98.
8. Laitala, V.S., Kaprio, J. and Silventoinen, K. (2008) Genetics of coffee consumption and its stability. Addiction, 103, 2054-2061.
9. Vink, J.M., Staphorsius, A.S. and Boomsma, D.I. (2009) A genetic analysis of coffee consumption in a sample of Dutch twins. Twin Res. Hum. Genet., 12, 127-131.
10. (2005) A haplotype map of the human genome. Nature, 437, 1299-1320.
11. Rodrigues, A.D. (1999) Integrated cytochrome P450 reaction phenotyping: attempting to bridge the gap between cDNA-expressed cytochromes P450 and native human liver microsomes. Biochem. Pharmacol., 57, 465-480.
12. Faber, M.S., Jetter, A. and Fuhr, U. (2005) Assessment of CYP1A2 activity in clinical practice: why, how, and when? Basic Clin. Pharmacol. Toxicol., 97, 125-134.
13. Nukaya, M. and Bradfield, C.A. (2009) Conserved genomic structure of the Cyp1a1 and Cyp1a2 loci and their dioxin responsive elements cluster. Biochem. Pharmacol., 77, 654-659.
14. Nukaya, M., Moran, S. and Bradfield, C.A. (2009) The role of the dioxin-responsive element cluster between the Cyp1a1 and Cyp1a2 loci in aryl hydrocarbon receptor biology. Proc. Natl Acad. Sci. USA, 106, 4923-4928.
15. Sachse, C., Brockmoller, J., Bauer, S. and Roots, I. (1999) Functional significance of a C->A polymorphism in intron 1 of the cytochrome P450 CYP1A2 gene tested with caffeine. Br. J. Clin. Pharmacol., 47, 445-449.
16. Djordjevic, N., Ghotbi, R., Bertilsson, L., Jankovic, S. and Aklillu, E. (2008) Induction of CYP1A2 by heavy coffee consumption in Serbs and Swedes. Eur. J. Clin. Pharmacol., 64, 381-385.
17. Tantcheva-Poor, I., Zaigler, M., Rietbrock, S. and Fuhr, U. (1999) Estimation of cytochrome P-450 CYP1A2 activity in 863 healthy Caucasians using a saliva-based caffeine test. Pharmacogenetics, 9, 131-144.
18. Saccone, S.F., Hinrichs, A.L., Saccone, N.L., Chase, G.A., Konvicka, K., Madden, P.A., Breslau, N., Johnson, E.O., Hatsukami, D., Pomerleau, O. et al. (2007) Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study targeting 348 candidate genes with 3713 SNPs. Hum. Mol. Genet., 16, 36-49.
19. Thorgeirsson, T.E., Geller, F., Sulem, P., Rafnar, T., Wiste, A., Magnusson, K.P., Manolescu, A., Thorleifsson, G., Stefansson, H., Ingason, A. et al. (2008) A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature, 452, 638-642.
20. Newton-Cheh, C., Johnson, T., Gateva, V., Tobin, M.D., Bochud, M., Coin, L., Najjar, S.S., Zhao, J.H., Heath, S.C., Eyheramendy, S. et al. (2009) Genome-wide association study identifies eight loci associated with blood pressure. Nat. Genet., 41, 666-676.
21. Levy, D., Ehret, G.B., Rice, K., Verwoert, G.C., Launer, L.J., Dehghan, A., Glazer, N.L., Morrison, A.C., Johnson, A.D., Aspelund, T. et al. (2009) Genome-wide association study of blood pressure and hypertension. Nat. Genet., 41, 677-687.
22. Carrillo, J.A. and Benitez, J. (1996) CYP1A2 activity, gender and smoking, as variables influencing the toxicity of caffeine. Br. J. Clin. Pharmacol., 41, 605-608.
23. Kiemeney, L.A., Thorlacius, S., Sulem, P., Geller, F., Aben, K.K., Stacey, S.N., Gudmundsson, J., Jakobsdottir, M., Bergthorsson, J.T., Sigurdsson, A. et al. (2008) Sequence variant on 8q24 confers susceptibility to urinary bladder cancer. Nat. Genet., 40, 1307-1312.
24. Kutyavin, I.V., Milesi, D., Belousov, Y., Podyminogin, M., Vorobiev, A., Gorn, V., Lukhtanov, E.A., Vermeulen, N.M. and Mahoney, W. (2006) A novel endonuclease IV post-PCR genotyping system. Nucleic Acids Res., 34, e128.
25. Marchini, J., Howie, B., Myers, S., McVean, G. and Donnelly, P. (2007) A new multipoint method for genome-wide association studies by imputation of genotypes. Nat. Genet., 39, 906-913.
26. Gretarsdottir, S., Thorleifsson, G., Reynisdottir, S.T., Manolescu, A., Jonsdottir, S., Jonsdottir, T., Gudmundsdottir, T., Bjarnadottir, S.M., Einarsson, O.B., Gudjonsdottir, H.M. et al. (2003) The gene encoding phosphodiesterase 4D confers risk of ischemic stroke. Nat. Genet., 35, 131-138.
27. Rice, J.A. (1995) Mathematical Statistics and Data Analysis. Wadsworth Inc., Belmont, CA.
28. Devlin, B. and Roeder, K. (1999) Genomic control for association studies. Biometrics, 55, 997-1004.
29. Higgins, J.P. and Thompson, S.G. (2002) Quantifying heterogeneity in a meta-analysis. Stat. Med., 21, 1539-1558.